An investigation into a 4T1 breast cancer model revealed significantly higher IL-33 expression within tumor tissue, implying an immune response to 4T1 cells as a potential primary source of IL-33 in the tumor microenvironment [58]. The gene discussed is IL33; the disease is neoplasm.